Raymond James & Associates Acquires 16,856 Shares of KKR & Co. Inc. (NYSE:KKR)

Raymond James & Associates increased its position in shares of KKR & Co. Inc. (NYSE:KKR) by 1.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 978,885 shares of the asset manager’s stock after acquiring an additional 16,856 shares during the quarter. Raymond James & Associates owned about 0.11% of KKR & Co. Inc. worth $127,823,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the company. Riverview Trust Co acquired a new position in shares of KKR & Co. Inc. during the 1st quarter worth about $27,000. Versant Capital Management Inc raised its stake in KKR & Co. Inc. by 622.9% during the 2nd quarter. Versant Capital Management Inc now owns 253 shares of the asset manager’s stock worth $27,000 after buying an additional 218 shares during the period. Mather Group LLC. lifted its holdings in KKR & Co. Inc. by 371.4% during the second quarter. Mather Group LLC. now owns 264 shares of the asset manager’s stock worth $27,000 after acquiring an additional 208 shares in the last quarter. ORG Wealth Partners LLC acquired a new position in KKR & Co. Inc. in the third quarter valued at about $31,000. Finally, American National Bank raised its position in shares of KKR & Co. Inc. by 202.6% during the second quarter. American National Bank now owns 351 shares of the asset manager’s stock worth $37,000 after purchasing an additional 235 shares during the period. Institutional investors own 76.26% of the company’s stock.

KKR & Co. Inc. Price Performance

Shares of KKR opened at $139.81 on Friday. KKR & Co. Inc. has a fifty-two week low of $53.72 and a fifty-two week high of $140.15. The firm has a market capitalization of $124.07 billion, a PE ratio of 31.35, a PEG ratio of 1.14 and a beta of 1.62. The company’s 50-day moving average is $126.16 and its 200-day moving average is $112.68. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.07 and a quick ratio of 0.07.

KKR & Co. Inc. (NYSE:KKR) last posted its earnings results on Wednesday, July 31st. The asset manager reported $1.09 earnings per share for the quarter, topping analysts’ consensus estimates of $0.89 by $0.20. KKR & Co. Inc. had a return on equity of 5.05% and a net margin of 17.99%. The company had revenue of $4.17 billion during the quarter, compared to the consensus estimate of $1.07 billion. During the same quarter last year, the firm earned $0.58 earnings per share. Equities analysts forecast that KKR & Co. Inc. will post 3.97 EPS for the current year.

KKR & Co. Inc. Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, August 27th. Stockholders of record on Monday, August 12th were given a $0.175 dividend. The ex-dividend date of this dividend was Monday, August 12th. This represents a $0.70 dividend on an annualized basis and a dividend yield of 0.50%. KKR & Co. Inc.’s payout ratio is 15.70%.

Insider Activity at KKR & Co. Inc.

In other KKR & Co. Inc. news, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of KKR & Co. Inc. stock in a transaction on Friday, September 13th. The stock was sold at an average price of $25.75, for a total value of $149,350,000.00. Following the completion of the transaction, the insider now directly owns 25,260,971 shares of the company’s stock, valued at $650,470,003.25. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, major shareholder Kkr Group Partnership L.P. purchased 11,619,998 shares of KKR & Co. Inc. stock in a transaction dated Wednesday, September 11th. The shares were bought at an average cost of $11.13 per share, for a total transaction of $129,330,577.74. Following the purchase, the insider now owns 92,959,984 shares in the company, valued at approximately $1,034,644,621.92. This trade represents a 0.00 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the firm’s stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $25.75, for a total transaction of $149,350,000.00. Following the completion of the sale, the insider now owns 25,260,971 shares in the company, valued at $650,470,003.25. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 39.34% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on KKR. StockNews.com raised KKR & Co. Inc. to a “sell” rating in a research note on Monday, October 7th. Morgan Stanley raised their price objective on shares of KKR & Co. Inc. from $107.00 to $143.00 and gave the stock an “equal weight” rating in a report on Thursday, October 10th. Keefe, Bruyette & Woods reaffirmed an “outperform” rating and issued a $144.00 target price (up from $125.00) on shares of KKR & Co. Inc. in a research note on Thursday, August 1st. Wells Fargo & Company boosted their price target on KKR & Co. Inc. from $130.00 to $139.00 and gave the company an “equal weight” rating in a report on Wednesday, October 9th. Finally, Redburn Atlantic began coverage on KKR & Co. Inc. in a report on Tuesday, August 27th. They set a “buy” rating and a $153.00 price objective for the company. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $144.43.

KKR & Co. Inc. Profile

KKR & Co Inc is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments.